Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

prorenoate potassium

Known as: potassium prorenoate 
The potassium salt form of prorenoate, a steroidal aldosterone antagonist with potassium-sparing diuretic activity. Prorenoate antagonizes the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
We have previously reported our studies on glucocorticoid (GC) effects on Na+ influx in vascular smooth muscle (VSM) cells. We… Expand
Is this relevant?
1993
1993
We have previously demonstrated that receptors to both mineralocorticoids (MC) and glucocorticoids (GC) exist in the arterial… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
1985
1985
A 3-month dose range finding study in preparation for a 2-yr carcinogenicity study of potassium prorenoate (SC-23992), a steroid… Expand
  • table I
  • table I
  • table I
  • table IV
  • table V
Is this relevant?
1984
1984
The plasma potassium responses to the aldosterone antagonists prorenoate K (10 mg/day and 40 mg/day) and spironolactone (25 mg… Expand
Is this relevant?
1982
1982
A perifusion technique using frog adrenal glands has been applied to investigate the effects of long-term administration of a new… Expand
Is this relevant?
1979
1979
To investigate the possible direct effect of two aldosterone antagonists (Canrenoate-K and Prorenoate-K) upon mineralocorticoid… Expand
Is this relevant?
1979
1979
Two new aldosterone antagonists, K-prorenoate [potassium 3(17 beta-hydroxy-6 beta, 7 beta-methylen-3-oxo-4-androsten-17 alpha-yl… Expand
Is this relevant?
1976
1976
SummaryThe pharmacological activity of single oral doses of a new aldosterone antagonist, prorenoate potassium, has been compared… Expand
  • table I
  • table 2
  • figure 3
  • figure 2
Is this relevant?
1976
1976
1 The pharmacodynamic profile of single oral doses of prorenoate potassium (40 mg) and spironolactone (100 mg), as judged by… Expand
Is this relevant?
1975
1975
The potency of single doses of a new aldosterone antagonist, prorenoate, in reversing the renal effects of the synthetic… Expand
Is this relevant?